Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $2.12B.
ENTERPRISE VALUE (EV)
$2.12B
Nurix Therapeutics, Inc.
Market Cap
$2.36B
Enterprise Value (EV)
$2.12B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Nurix Therapeutics, Inc. (NRIX) | $2.36B | $2.12B |
| Alamar Biosciences, Inc. (ALMR)vs › | $2.38B | $2.30B |
| Liquidia Corporation (LQDA)vs › | $2.36B | $2.20B |
| ADMA Biologics, Inc. (ADMA)vs › | $2.38B | $2.45B |
| Clover Health Investments, Corp. (CLOV)vs › | $2.40B | $2.20B |
| Harmony Biosciences Holdings, Inc. (HRMY)vs › | $2.30B | $1.90B |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.44B | $1.96B |
| Disc Medicine, Inc. (IRON)vs › | $2.45B | $2.41B |
| Maravai LifeSciences Holdings, Inc. (MRVI)vs › | $2.29B | $2.39B |
| Privia Health Group, Inc. (PRVA)vs › | $2.58B | N/A |
Market Cap
$2.36B
Total Debt
$0.00
Cash
$246.96M
Enterprise Value
$2.12B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
